These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9784876)

  • 21. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y; Ore MO; Morin S; Wilson DJ
    Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
    Faria TQ; Almeida ZL; Cruz PF; Jesus CS; Castanheira P; Brito RM
    Phys Chem Chem Phys; 2015 Mar; 17(11):7255-63. PubMed ID: 25694367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
    Julius RL; Farha OK; Chiang J; Perry LJ; Hawthorne MF
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4808-13. PubMed ID: 17360344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.
    Purkey HE; Dorrell MI; Kelly JW
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5566-71. PubMed ID: 11344299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.
    Gorevic PD; Prelli FC; Wright J; Pras M; Frangione B
    J Clin Invest; 1989 Mar; 83(3):836-43. PubMed ID: 2646319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses.
    Almeida MR; Gales L; Damas AM; Cardoso I; Saraiva MJ
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):587-96. PubMed ID: 16266291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibril in senile systemic amyloidosis is derived from normal transthyretin.
    Westermark P; Sletten K; Johansson B; Cornwell GG
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2843-5. PubMed ID: 2320592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
    Green NS; Foss TR; Kelly JW
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies.
    Leri M; Nosi D; Natalello A; Porcari R; Ramazzotti M; Chiti F; Bellotti V; Doglia SM; Stefani M; Bucciantini M
    J Nutr Biochem; 2016 Apr; 30():153-66. PubMed ID: 27012632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis].
    Ikeda SI
    Brain Nerve; 2013 Jul; 65(7):831-42. PubMed ID: 23832986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.
    Colon W; Kelly JW
    Biochemistry; 1992 Sep; 31(36):8654-60. PubMed ID: 1390650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid disease prevention by transthyretin native state complexation with carborane derivatives lacking cyclooxygenase inhibition.
    Julius RL; Hawthorne MF
    Drug News Perspect; 2008 Jun; 21(5):258-66. PubMed ID: 18596990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis.
    Chung CM; Connors LH; Benson MD; Walsh MT
    Amyloid; 2001 Jun; 8(2):75-83. PubMed ID: 11409037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperative stabilization of transthyretin by clusterin and diflunisal.
    Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
    Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments.
    Yokoyama T; Mizuguchi M
    J Med Chem; 2020 Dec; 63(23):14228-14242. PubMed ID: 32914975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
    Hoepfner J; Kleinsorge M; Papp O; Alfken S; Heiringhoff R; Pich A; Sauer V; Zibert A; Göhring G; Schmidt H; Sgodda M; Cantz T
    Biol Chem; 2017 Jul; 398(8):939-954. PubMed ID: 28051995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization.
    Raghu P; Reddy GB; Sivakumar B
    Arch Biochem Biophys; 2002 Apr; 400(1):43-7. PubMed ID: 11913969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
    Dolado I; Nieto J; Saraiva MJ; Arsequell G; Valencia G; Planas A
    J Comb Chem; 2005; 7(2):246-52. PubMed ID: 15762752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.